Article Figures & Data
Figures
- Figure 1.
Selection of procedures for inclusion in analysis
Tables
CHARACTERISTIC NO DIABETES COMORBIDITY (N = 1289), N (%) DIABETES COMORBIDITY (N = 45), N (%) TOTAL (N = 1334), N (%) Age, y • ≤ 12 101 (7.8) 2 (4.4) 103 (7.7) • 13–18 470 (36.5) 2 (4.4) 472 (35.4) • 19–64 667 (51.7) 30 (66.7) 697 (52.2) • > 64 51 (4.0) 11 (24.4) 62 (4.6) Procedure • Nail fold skin excision 1172 (90.9) 36 (80.0) 1208 (90.6) • Partial nail avulsion 50 (3.9) 4 (8.9) 54 (4.0) • Complete nail avulsion 57 (4.4) 5 (11.1) 62 (4.6) • Cautery and curettage 10 (0.8) 0 (0.0) 10 (0.7) Vasopressor concentration • Epinephrine 1:100 000 1127 (87.4) 38 (84.4) 1165 (87.3) • Epinephrine 1:200 000 162 (12.6) 7 (15.6) 169 (12.7) COMPLICATION NO DIABETES COMORBIDITY (N = 1289), N (%) DIABETES COMORBIDITY (N = 45), N (%) P VALUE Total 59 (4.6) 2 (4.4) .661 Digital necrosis or ischemia 0 (0.0) 0 (0.0) NA Infection • Localized to toe 38 (2.9) 1 (2.2) .618 • Extension to foot 1 (0.1) 0 (0.0) .966 Persistent granulation 9 (0.7) 0 (0.0) .734 Reperfusion injury 7 (0.5) 0 (0.0) .786 Neuropathy 3 (0.2) 1 (2.2) .128 Onychomycosis 1 (0.1) 0 (0.0) .966 NA—not applicable.
